Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1600 participants
OBSERVATIONAL
2024-06-20
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Determine the number of mycetoma cases diagnosed per year and trends over time.
* Describe characteristics of diagnosed mycetoma cases.
1. Describe demographic characteristics of patients with mycetoma.
2. Describe clinical characteristics of patients with mycetoma upon initial presentation and over time.
* Assess etiology of mycetoma cases.
* Characterize clinical management of mycetoma cases.
1. Characterize approaches to diagnosis of mycetoma.
2. Investigate types and durations of treatments (including medical and surgical approaches) utilized to treat mycetoma cases.
3. Describe clinical outcomes among patients with mycetoma.
The study team will review all available medical, laboratory and radiologic records of identified mycetoma cases and use data collection forms to extract relevant data.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eumycetoma Long-term Post-Treatment Follow-Up Study
NCT06514183
Observing People With Desmoid-Type Fibromatosis
NCT04281381
Surveillance of Association of Immune Status and Prognosis of CNS Germ Cell Tumor Survivors
NCT04909307
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
NCT01265030
The Etiology and Progression of Brain Tumors
NCT01811524
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study, a retrospective review of mycetoma cases, aims to generate such data from several countries suggested by preliminary data to potentially be good candidate clinical trial sites.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A diagnosis of mycetoma in a medical, radiologic, or laboratory record.
For each patient, data will be extracted for each clinical, laboratory or radiologic visit related to the condition that may meet this study's case definition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cheikh Anta Diop University, Senegal
OTHER
Post Graduate Institute of Medical Education and Research, Chandigarh
OTHER
Drugs for Neglected Diseases
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Doudou Sow, PhD
Role: PRINCIPAL_INVESTIGATOR
Université Gaston Berger
Shivaprakash M Rudramurthy, M.D
Role: PRINCIPAL_INVESTIGATOR
Post Graduate Institute of Medical Education and Research, Chandigarh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Postgraduate Institute of Medical Education and Research
Chandigarh, , India
Universite Cheikh Anta Diop de Dakar
Dakar, , Senegal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shivaprakash M Rudramurthy, M.D
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DNDi-OBS-03-MYC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.